| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | selumetinib:decitabine (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | 0.02 | 0.5 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | 0.018 | 0.5 |
| mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | QL-XII-47 | GDSC1000 | pan-cancer | AAC | 0.02 | 0.5 |
| mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | 0.022 | 0.5 |